- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 37/02 - Immunomodulators
Patent holdings for IPC class A61P 37/02
Total number of patents in this class: 5621
10-year publication summary
|
183
|
283
|
419
|
399
|
550
|
551
|
568
|
521
|
402
|
180
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2721 |
43 |
| Daiichi Sankyo Company, Limited | 1888 |
38 |
| The Regents of the University of California | 20556 |
35 |
| Ono Pharmaceutical Co., Ltd. | 419 |
30 |
| Regeneron Pharmaceuticals, Inc. | 4608 |
30 |
| Bristol-myers Squibb Company | 4812 |
29 |
| The University of Tokyo | 4328 |
27 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 677 |
26 |
| F. Hoffmann-La Roche AG | 7839 |
24 |
| The Board of Trustees of the Leland Stanford Junior University | 6592 |
24 |
| The Trustees of the University of Pennsylvania | 4406 |
23 |
| Chugai Seiyaku Kabushiki Kaisha | 1393 |
23 |
| Mitsubishi Tanabe Pharma Corporation | 429 |
23 |
| Osaka University | 3304 |
23 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 858 |
23 |
| Novartis AG | 10345 |
22 |
| Taisho Pharmaceutical Co., Ltd. | 858 |
22 |
| Dana-Farber Cancer Institute, Inc. | 2645 |
20 |
| The Brigham and Women's Hospital, Inc. | 2264 |
19 |
| Jiangsu Hengrui Medicine Co., Ltd. | 695 |
19 |
| Other owners | 5098 |